GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Gross-Profit-to-Asset %

Instituto Rosenbusch (BUE:ROSE) Gross-Profit-to-Asset % : 48.51% (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Instituto Rosenbusch Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Instituto Rosenbusch's annualized Gross Profit for the quarter that ended in Dec. 2024 was ARS3,652 Mil. Instituto Rosenbusch's average Total Assets over the quarter that ended in Dec. 2024 was ARS7,530 Mil. Therefore, Instituto Rosenbusch's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 48.51%.

Instituto Rosenbusch Gross-Profit-to-Asset % Historical Data

The historical data trend for Instituto Rosenbusch's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instituto Rosenbusch Gross-Profit-to-Asset % Chart

Instituto Rosenbusch Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.91 25.17 70.72 62.94 60.91

Instituto Rosenbusch Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 159.47 94.48 46.18 42.18 48.51

Competitive Comparison of Instituto Rosenbusch's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Instituto Rosenbusch's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Instituto Rosenbusch's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Instituto Rosenbusch's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Instituto Rosenbusch's Gross-Profit-to-Asset % falls into.


;
;

Instituto Rosenbusch Gross-Profit-to-Asset % Calculation

Instituto Rosenbusch's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=3832.402/( (5042.761+7542.017)/ 2 )
=3832.402/6292.389
=60.91 %

Instituto Rosenbusch's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Sep. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=3652.312/( (7517.11+7542.017)/ 2 )
=3652.312/7529.5635
=48.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Instituto Rosenbusch Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Instituto Rosenbusch's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Instituto Rosenbusch Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instituto Rosenbusch SA (BUE:ROSE) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257 NBIX
Traded in Other Exchanges
N/A
Address
Hipolito Yrigoyen 1628, Buenos Aires, ARG, C1089AAF
Website
https://www.rosenbusch.com
Instituto Rosenbusch SA is a pharmaceutical company based in Argentina. The company is engaged in the processing and industrialization of biological, chemical, pharmaceutical products of any kind, nature or destination, preferably for veterinary use or intended to combat pests and diseases of the agricultural exploitation. The company has line of products such as Biologicals and pharmaceuticals. Biologicals offer Campy 3, Cultivac 6M and Bovine Antibrucelosis. Pharmaceuticals offer Diclosan A Intrammamary, Diclosan S Intrammamary and Mastilina V-S.